IP Library Granted Patent US 9,157,085
Granted Patent B2
US 9,157,085 · App. 12/995,924 · Granted Oct 13, 2015

Expression vector for expression of eukaryotic secretion leader sequence fused with a target polypeptide and methods of use thereof

Inventors: Bhupendra Vallabh Kara (Billingham, GB); Christopher David John Lennon (Billingham, GB)
Assignee: Fujifilm Diosynth Biotechnologies UK Limited
C12N15/625C12N15/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,157,085
App. No.
12/995,924
Granted
Oct 13, 2015
Kind
B2
Abstract

An expression vector for expressing a target polypeptide in a prokaryotic cell is provided. The vector comprises a promoter operably linked to a polynucleotide encoding the target polypeptide operably linked to a eukaryotic secretion leader sequence, the eukaryotic secretion leader sequence encoding a signal peptide sequence selected from the group consisting of: a) MLKRSSWLATLGLLTVASVSTIVYA; b) MKKATFITCLLAVLLVSNPIWNA; c) MKVSAAALAVILIATALCAPASA; d) MKVSTAFLCLLLTVSAFSAQVLA; and e) MKCLLLALGLALACAAQA. Processes for expressing polypeptides and prokaryotic microorganisms comprising such vectors are also provided.

Claims (20)

1. A prokaryotic expression vector comprising

(a) a prokaryotic promoter operably linked to a heterologous polynucleotide encoding a target polypeptide operably linked to a polynucleotide encoding a eukaryotic secretion leader which is a signal peptide having an amino acid sequence at least 90% identical to SEQ ID NO: 4 and is having a function of secreting the target polypeptide to a periplasmic space of a prokaryotic host cell; and

(b) at least one perfect palindrome operator sequence.

2. The prokaryotic expression vector according to claim 1 , wherein the signal peptide has a sequence at least 95% identical to SEQ ID NO: 4.

3. The prokaryotic expression vector according to claim 2 , wherein the polynucleotide encoding the target polypeptide operably linked to the eukaryotic secretion leader sequence has a structure such that a polynucleotide encoding the eukaryotic secretion leader sequence is attached at the 5′ end of the polynucleotide encoding the target polypeptide.

4. The prokaryotic expression vector according to claim 3 , wherein the expression vector is a plasmid and the target polypeptide is selected from the group consisting of cytokines, growth factors, antibodies, antibody fragments, immunoglobulin like polypeptides, enzyme, vaccines, peptide hormones, chemokines, receptors, receptor fragments, kinases, phosphatases, isomerases, hydrolyases, transcription factors and fusion polypeptides.

5. The prokaryotic expression vector according to claim 1 , wherein the polynucleotide encoding the target polypeptide operably linked to the eukaryotic secretion leader sequence has a structure such that a polynucleotide encoding the eukaryotic secretion leader sequence is attached at the 5′ end of the polynucleotide encoding the target polypeptide.

6. The prokaryotic expression vector according to claim 1 , wherein the vector is a plasmid.

7. The prokaryotic expression vector according to claim 1 , wherein the target polypeptide is selected from the group consisting of cytokines, growth factors, antibodies, antibody fragments, immunoglobulin like polypeptides, enzyme, vaccines, peptide hormones, chemokines, receptors, receptor fragments, kinases, phosphatases, isomerases, hydrolyases, transcription factors and fusion polypeptides.

8. The prokaryotic expression vector according to claim 1 , wherein the eukaryotic secretion leader sequence encodes the signal peptide of SEQ ID NO: 4.

9. The prokaryotic expression vector according to claim 1 , wherein the prokaryotic promoter is an E. coli RNA polymerase-based promoter system.

10. The prokaryotic expression vector according to claim 1 , wherein the heterologous polynucleotide encoding the eukaryotic secretion leader comprises the nucleotide sequence from position 4 to position 72 of SEQ ID NO: 16.

11. The prokaryotic expression vector according to claim 1 , wherein the signal peptide has the amino acid sequence of SEQ ID NO: 4.

12. A prokaryotic microorganism comprising the prokaryotic expression vector according to claim 1 .

13. The prokaryotic microorganism according to claim 12 , wherein the microorganism is selected from the group consisting of E. coli, Salmonella typhimurium, Serratia marsescens, Pseudomonas putida, Pseudomonas aeruginosa , and Bacillus subtilis.

14. A method for the production of a target polypeptide which comprises expressing the prokaryotic expression vector according to claim 1 in a prokaryotic host cell.

15. The method according to claim 14 , wherein the prokaryotic host cell is selected from the group consisting of E. coli, Salmonella typhimurium, Serratia marsescens, Pseudomonas aeruginosa, Pseudomonas putida and Bacillus subtilis.

16. A method for producing a target polypeptide which comprises:

a) culturing a prokaryotic host cell comprising the prokaryotic expression vector according to claim 1 , thereby to express the target polypeptide, and

b) recovering the target polypeptide.

Assignments (2)
CHANGE OF NAME Recorded Aug 2, 2011
From: MSD BIOLOGICS (UK) LIMITED
To: FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED
Reel/Frame 026685/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2010
From: KARA, BHUPENDRA VALLABH; LENNON, CHRISTOPHER DAVID JOHN
To: MSD BIOLOGICS (UK) LIMITED
Reel/Frame 025443/0403 →
Priority Claims (1)
GB 0810154.5 · Jun 4, 2008 · national
Continuity (1)
Related Publication 20110086391A1 · Apr 14, 2011